Insider filing · MNPR
Monopar Therapeutics Inc.
MNPR · Healthcare · 11 filings in 24 months
ticker →
Tactic Pharma LLC sold $1.2M of Monopar Therapeutics (MNPR)
Executed Apr 2 2025, disclosed Apr 4 2025, 2 days later.
Value, as filed
$1.2M
33,334 sh × $35.00
Executed
Apr 2 2025
the trade date, as filed
Disclosed
Apr 4 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TL
Tactic Pharma LLC
Chief Executive Officer
profile →
Tactic Pharma LLC (Chief Executive Officer) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $35.0M of MNPR (550,229 sh × $63.61, as filed), executed Sep 24 2025.
The name
MNPRHealthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Tactic Pharma LLC in MNPR
MNPRSALE
Monopar Therapeutics Inc.
$35.0M550,229 sh × $63.61
Exec Sep 24 2025
Filed Sep 26 2025 · 5:30 PM ET